PURPOSE: We previously observed that poor DNA repair phenotype is associated with increased breast cancer (BC) risk within families. Here, we examined whether genetic variation in double-strand break repair (DSBR) genes is associated with BC risk and if genotypes are related to phenotype in unaffected women. METHODS: Using data from the New York site of the Breast Cancer Family Registry, we investigated 25 single-nucleotide polymorphism (SNPs) involved in DSBR using biospecimens from 337 BC cases and 410 unaffected sister controls. RESULTS: Genotypes in XRCC4 were associated with BC risk, with ORs of 1.67 (95 % CI 1.01-2.76) for the combined GA/AA of rs1805377 and 1.69 (95 % CI 1.03-2.77) for rs1056503 TG/GG; these associations were no longer statistically significant in multivariable conditional logistic regression models. When examining the association of SNPs with phenotype, we found that genotypes of XRCC5 rs3834 and rs1051685, which were highly correlated with each other, were associated with end-joining (EJ) capacity; women with the XRCC5 rs3834 GA genotype had better DNA repair as measured by higher levels of EJ capacity (37.8 ± 14.1 % for GA vs. 27.9 ± 11.8 % for GG carriers p = 0.0006). Women with the AA genotype of BRCA1 rs799917 also had higher EJ capacity (35.1 ± 9.2 %) than those with GG (26.4 ± 10.1 %, p = 0.02). CONCLUSIONS: Overall, we found that selected DSBR genotypes were associated with phenotype, although they were not associated with BC risk itself, suggesting that phenotypic measures are influenced by endogenous and exogenous factors across the life course and may be better markers than genotypic measures for ascertaining BC risk.
PURPOSE: We previously observed that poor DNA repair phenotype is associated with increased breast cancer (BC) risk within families. Here, we examined whether genetic variation in double-strand break repair (DSBR) genes is associated with BC risk and if genotypes are related to phenotype in unaffected women. METHODS: Using data from the New York site of the Breast Cancer Family Registry, we investigated 25 single-nucleotide polymorphism (SNPs) involved in DSBR using biospecimens from 337 BC cases and 410 unaffected sister controls. RESULTS: Genotypes in XRCC4 were associated with BC risk, with ORs of 1.67 (95 % CI 1.01-2.76) for the combined GA/AA of rs1805377 and 1.69 (95 % CI 1.03-2.77) for rs1056503TG/GG; these associations were no longer statistically significant in multivariable conditional logistic regression models. When examining the association of SNPs with phenotype, we found that genotypes of XRCC5rs3834 and rs1051685, which were highly correlated with each other, were associated with end-joining (EJ) capacity; women with the XRCC5rs3834 GA genotype had better DNA repair as measured by higher levels of EJ capacity (37.8 ± 14.1 % for GA vs. 27.9 ± 11.8 % for GG carriers p = 0.0006). Women with the AA genotype of BRCA1 rs799917 also had higher EJ capacity (35.1 ± 9.2 %) than those with GG (26.4 ± 10.1 %, p = 0.02). CONCLUSIONS: Overall, we found that selected DSBR genotypes were associated with phenotype, although they were not associated with BC risk itself, suggesting that phenotypic measures are influenced by endogenous and exogenous factors across the life course and may be better markers than genotypic measures for ascertaining BC risk.
Authors: Bettina Kuschel; Annika Auranen; Simon McBride; Karen L Novik; Antonis Antoniou; Julian M Lipscombe; Nicholas E Day; Douglas F Easton; Bruce A J Ponder; Paul D P Pharoah; Alison Dunning Journal: Hum Mol Genet Date: 2002-06-01 Impact factor: 6.150
Authors: Kristina Allen-Brady; Lisa A Cannon-Albright; Susan L Neuhausen; Nicola J Camp Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-07 Impact factor: 4.254
Authors: Lissette Delgado-Cruzata; Hui-Chen Wu; Mary Perrin; Yuyan Liao; Maya A Kappil; Jennifer S Ferris; Julie D Flom; Hulya Yazici; Regina M Santella; Mary Beth Terry Journal: Epigenetics Date: 2012-06-18 Impact factor: 4.528
Authors: Hui-Chen Wu; Lissette Delgado-Cruzata; Julie D Flom; Mary Perrin; Yuyan Liao; Jennifer S Ferris; Regina M Santella; Mary Beth Terry Journal: Carcinogenesis Date: 2012-06-07 Impact factor: 4.944
Authors: Jonine D Figueroa; Montserrat Garcia-Closas; Manjeet Humphreys; Radka Platte; John L Hopper; Melissa C Southey; Carmel Apicella; Fleur Hammet; Marjanka K Schmidt; Annegien Broeks; Rob A E M Tollenaar; Laura J Van't Veer; Peter A Fasching; Matthias W Beckmann; Arif B Ekici; Reiner Strick; Julian Peto; Isabel dos Santos Silva; Olivia Fletcher; Nichola Johnson; Elinor Sawyer; Ian Tomlinson; Michael Kerin; Barbara Burwinkel; Federik Marme; Andreas Schneeweiss; Christof Sohn; Stig Bojesen; Henrik Flyger; Børge G Nordestgaard; Javier Benítez; Roger L Milne; Jose Ignacio Arias; M Pilar Zamora; Hermann Brenner; Heiko Müller; Volker Arndt; Nazneen Rahman; Clare Turnbull; Sheila Seal; Anthony Renwick; Hiltrud Brauch; Christina Justenhoven; Thomas Brüning; Jenny Chang-Claude; Rebecca Hein; Shan Wang-Gohrke; Thilo Dörk; Peter Schürmann; Michael Bremer; Peter Hillemanns; Heli Nevanlinna; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; Natalia Bogdanova; Natalia Antonenkova; Yuri I Rogov; Johann Hinrich Karstens; Marina Bermisheva; Darya Prokofieva; Shamil Hanafievich Gantcev; Elza Khusnutdinova; Annika Lindblom; Sara Margolin; Georgia Chenevix-Trench; Jonathan Beesley; Xiaoqing Chen; Arto Mannermaa; Veli-Matti Kosma; Ylermi Soini; Vesa Kataja; Diether Lambrechts; Betül T Yesilyurt; Marie-Rose Chrisiaens; Stephanie Peeters; Paolo Radice; Paolo Peterlongo; Siranoush Manoukian; Monica Barile; Fergus Couch; Adam M Lee; Robert Diasio; Xianshu Wang; Graham G Giles; Gianluca Severi; Laura Baglietto; Catriona Maclean; Ken Offit; Mark Robson; Vijai Joseph; Mia Gaudet; Esther M John; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Irene Andrulis; Julia A Knight; Anna Marie Mulligan; Frances P O'Malley; Louise A Brinton; Mark E Sherman; Jolanta Lissowska; Stephen J Chanock; Maartje Hooning; John W M Martens; Ans M W van den Ouweland; J Margriet Collée; Per Hall; Kamila Czene; Angela Cox; Ian W Brock; Malcolm W R Reed; Simon S Cross; Paul Pharoah; Alison M Dunning; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Sei-Hyun Ahn; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska; Katarzyna Durda; Suleeporn Sangrajrang; Valerie Gaborieau; Paul Brennan; James McKay; Chen-Yang Shen; Shian-ling Ding; Huan-Ming Hsu; Jyh-Cherng Yu; Hoda Anton-Culver; Argyrios Ziogas; Alan Ashworth; Anthony Swerdlow; Michael Jones; Nick Orr; Amy Trentham-Dietz; Kathleen Egan; Polly Newcomb; Linda Titus-Ernstoff; Doug Easton; Amanda B Spurdle Journal: Hum Mol Genet Date: 2011-08-18 Impact factor: 6.150
Authors: Luisel J Ricks-Santi; Lara E Sucheston; Yang Yang; Jo L Freudenheim; Claudine J Isaacs; Marc D Schwartz; Ramona G Dumitrescu; Catalin Marian; Jing Nie; Dominica Vito; Stephen B Edge; Peter G Shields Journal: BMC Cancer Date: 2011-06-27 Impact factor: 4.430
Authors: Hui-Chen Wu; Melissa C Southey; Hanina Hibshoosh; Regina M Santella; Mary Beth Terry Journal: Anticancer Res Date: 2017-02 Impact factor: 2.480
Authors: Tú Nguyen-Dumont; Fleur Hammet; Maryam Mahmoodi; Helen Tsimiklis; Zhi L Teo; Roger Li; Bernard J Pope; Mary Beth Terry; Saundra S Buys; Mary Daly; John L Hopper; Ingrid Winship; David E Goldgar; Daniel J Park; Melissa C Southey Journal: Breast Cancer Res Treat Date: 2015-01-10 Impact factor: 4.872
Authors: Mary Beth Terry; Theresa H M Keegan; Lauren C Houghton; Mandy Goldberg; Irene L Andrulis; Mary B Daly; Saundra S Buys; Ying Wei; Alice S Whittemore; Angeline Protacio; Angela R Bradbury; Wendy K Chung; Julia A Knight; Esther M John Journal: Breast Cancer Res Date: 2017-06-08 Impact factor: 6.466